Logotype for Cerus Corporation

Cerus (CERS) investor relations material

Cerus Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Cerus Corporation
Q3 2025 earnings summary6 Nov, 2025

Executive summary

  • Achieved record Q3 2025 product revenue of $52.7 million, up 15% year-over-year, driven by strong global platelet demand and rapid IFC adoption, with total Q3 revenue reaching $60.2 million, up 19%.

  • Raised full-year 2025 product revenue guidance to $202–$204 million, reflecting continued commercial momentum and global execution.

  • Sixth consecutive quarter of positive non-GAAP Adjusted EBITDA, totaling $5 million for Q3, with net loss narrowing to $20,000.

  • Transitioned IFC sales model from direct hospital sales to kit-based sales to blood centers, improving margins and market access.

  • Completed enrollment in U.S. phase III RedeS trial for red blood cells; results expected in H2 2026.

Financial highlights

  • Q3 2025 product revenue: $52.7 million (up 15% year-over-year); nine months: $148.4 million (up 15%).

  • Q3 government contract revenue: $7.5 million (up 63% year-over-year); nine months: $20.8 million (up 38%).

  • Q3 product gross profit was $28.1 million (up 7%); gross margin was 53.4%, down from 56.9% due to tariffs, inflation, and higher IFC costs.

  • Q3 operating expenses were $34.4 million; R&D expenses $15.8 million, SG&A $18.6 million.

  • Q3 net loss narrowed to $20,000; cash, cash equivalents, and short-term investments totaled $78.5–$79.7 million at quarter-end.

Outlook and guidance

  • Full-year 2025 product revenue guidance raised to $202–$204 million; IFC sales expected at $16–$17 million.

  • Expects to achieve positive full-year 2025 non-GAAP adjusted EBITDA and continued positive operating cash flow.

  • Anticipates strong Q4 with record revenue, continued INT200 installations, and further IFC kit adoption.

  • Government contract revenue anticipated to rise through 2026 as multiple contracts ramp up.

  • Management believes available liquidity is sufficient for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Cerus earnings date

Logotype for Cerus Corporation
Q4 202527 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Cerus earnings date

Logotype for Cerus Corporation
Q4 202527 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Cerus Corporation develops and markets blood safety technologies intended to reduce the risk of transfusion-transmitted infections. Its INTERCEPT platform is used to treat blood components such as platelets and plasma. The company serves blood centers, hospitals, and transfusion services. The company is headquartered in Concord, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage